FEB 14, 2019 10:30 AM PST

Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development

Speaker

Abstract

This presentation will discuss and review the promise and potential of 3D Microtissues, and the challenges of using these Microtissues as Hazard ID tools. Lastly, we will discuss the potential application of Neural Microtissues in drug discovery screening. 

Learning Objectives: 

1. Understanding the strengths and limitations of in vitro and in vivo assays for hazard identification and risk assessment.  
2. Examining how 3D Microtissues can improve hazard identification in drug discovery, and de-risking during drug development.  


You May Also Like
FEB 14, 2019 10:30 AM PST

Integrating In Vitro Microtissues and In Vivo endpoints in Drug Discovery & Development



Loading Comments...